Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Third Cardiovascular Giant Coming With $25 Bil. Abbott-St. Jude Deal

This article was originally published in The Gray Sheet

Executive Summary

The previously rumored acquisition was announced on April 28, with the firms touting their extensive synergies in the cardiovascular space.

Advertisement

Related Content

Top M&A Of 2016: Cast Your Vote!
Device/Diagnostics Quarterly Deal Statistics, Q2 2016
St. Jude Hacking-Risk Allegations: US FDA Continues Assessment, As Firm Files Lawsuit
Medtechs Should Not Play Dodgeball With Sales Force Effectiveness
Abbott Tried To Pull Out Of Alere Deal, But It Remains On For Now
Abbott Denies St. Jude Acquisition Report, But Here's How The Firms Line Up
VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec
Abbott Can Sell St. Jude’s Intravascular Assessment Tools Under Expanded Alliance
Boston Scientific, Guidant Close The Deal Following FTC Approval

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT034724

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel